1-4 of 4
Davine Hofste op Bruinink, MD MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Differential Effect of Upfront Intensification Treatment in Genetically Defined Myeloma Risk Groups - a Combined Analysis of ISS, Del17p and SKY92 Scores in the EMN-02/HOVON-95 MM Trial

Davine Hofste op Bruinink, MD MSc, Mark van Duin, PhD, Meral Beksac, MD, Christoph Driessen, MD, Heinz Ludwig, MD, Michael Vermeulen, BSc, Rowan Kuiper, MSc, Martin H van Vliet, PhD, Bronno van der Holt, PhD, Roman Hajek, MD PhD, Hans Erik Johnsen, MD Professor, Meletios A Dimopoulos, MD, Antonio Palumbo, MD, Michele Cavo, MD, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3186.
https://doi.org/10.1182/blood-2018-99-119873
Published: 2018
Journal Articles

Multiple Myeloma with a Deletion of Chromosome 17p: TP53 Mutations Are Highly Prevalent and Negatively Affect Prognosis

Davine Hofste op Bruinink, MD MSc, Hoogenboezem Remco, MSc, Mathijs A. Sanders, PhD, Christopher P Wardell, PhD, Cody Ashby, PhD, Eric M.J. Bindels, PhD, Claudia Erpelinck-Verschueren, BSc, Paulette van Strien, BSc, Jasper Koenders, BSc, François G. Kavelaars, BSc, Jie He, PhD, Mark Bailey, MSc, Tariq I Mughal, MD FRCP, Kristine Misund, PhD, Berna Beverloo, PhD, Bronno van der Holt, PhD, Ivo Touw, PhD, Anders Waage, MDPhD, Hervé Avet-Loiseau, MD PhD, Graham H Jackson, MD PhD, Gareth J Morgan, MD PhD, Brian A Walker, PhD, Pieter Sonneveld, MDPhD
Journal: Blood
Blood (2016) 128 (22): 3271.
https://doi.org/10.1182/blood.V128.22.3271.3271
Published: 2016
Journal Articles

Flowcytometric Minimal Residual Disease Assessment in the EMN-02/HOVON-95 MM Trial: Used Methods and a Comparison of Their Sensitivity

Davine Hofste op Bruinink, MD MSc, Stefania Oliva, MD, Lucie Rihova, PhD, Bronno van der Holt, PhD, Milena Gilestro, BSc, Jeroen G. te Marvelde, BSc, Pavla Vsianska, MSc, Alexander Schmitz, PhD, Helle Høholt, BSc, Hans Erik Johnsen, MDDMSc, Mario Boccadoro, MD, Roman Hajek, MD, Pieter Sonneveld, MD PhD, Antonio Palumbo, MD, Paola Omedè, PhD, Vincent H.J. van der Velden, PhD
Journal: Blood
Blood (2016) 128 (22): 2072.
https://doi.org/10.1182/blood.V128.22.2072.2072
Published: 2016
Journal Articles

M3P Sequencing Panel Identifies TP53 Mutational Status As a Prognostic Factor in Chemotherapy-Naive Multiple Myeloma

Davine Hofste op Bruinink, MD MSc, K. Martin Kortüm, MD, Mark van Duin, PhD, Mathijs A. Sanders, PhD, Remco Hoogenboezem, MSc, Michael Vermeulen, BSc, Laura Bruins, Jonathan Ahmann, Annemiek Broijl, MD PhD, Sonja Zweegman, MD PhD, Esteban Braggio, PhD, Bronno van der Holt, PhD, A. Keith Stewart, MD PhD, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2984.
https://doi.org/10.1182/blood.V126.23.2984.2984
Published: 2015